Macrophage protects mycoplasma-infected chronic myeloid leukaemia cells from NK cell killing.
Macrophage (Mϕ) has been reported to downmodulate the cytotoxicity of natural killer (NK) cell against solid tumour cells. However, the collaborative role between NK cell and Mϕ remains underappreciated, especially in haematological cancers, such as chronic myeloid leukaemia (CML). We observed higher ratio of innate immune cells (Mϕ and NK) to adaptive immune cells (T and B cells) in CML bone marrow aspirates, prompting us to investigate the roles of NK and Mϕ in CML. Using co-culture models simulating the tumour inflammatory environment, we observed that Mϕ protects CML from NK attack only when CML was itself mycoplasma-infected and under chronic infection-inflammation condition. We found that the Mϕ protective effect on CML was associated with the maintenance of CD16 level on the NK cell membrane. Although the NK membrane CD16 (mCD16) was actively shed in Mϕ+NK+CML trio-culture, the NK mCD16 level was maintained, and this was independent of the modulation of sheddase by TIMP-1 or inhibitory cytokine TGFβ. Instead, we found that this process of NK mCD16 maintenance was conferred by Mϕ in a contact-dependent manner. We propose a new perspective on anti-CML strategy through abrogating Mϕ-mediated retention of NK surface CD16.